Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey

Basit Öğe Kaydı
dc.authoridKARAALI, Ridvan/0000-0003-2440-7529
dc.authoridKARABAY, OGUZ/0000-0003-1514-1685
dc.authoridErben, Nurettin/0000-0003-0373-0132
dc.authoridYILDIZ, ILKNUR ESEN/0000-0003-2987-0483
dc.authoridhizel, kenan/0000-0001-8644-139X
dc.authoridYildiz Kaya, Sibel/0000-0002-6319-7889
dc.contributor.authorOnlen, Yusuf
dc.contributor.authorBal, Tayibe
dc.contributor.authorCabalak, Mehmet
dc.contributor.authorOztoprak, Nefise Cuvalci
dc.contributor.authorSari, Nagehan Didem
dc.contributor.authorKurtaran, Behice
dc.contributor.authorSenates, Ebubekir
dc.date.accessioned2024-09-18T19:52:29Z
dc.date.available2024-09-18T19:52:29Z
dc.date.issued2022
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractBackground: The number and proportion of elderly patients living with chronic hepatitis C are expected to increase in the coming years. We aimed to compare the real-world efficacy and safety of direct-acting antiviral treatment in elderly and younger Turkish adults infected with chronic hepatitis C. Methods: In this multicenter prospective study, 2629 eligible chronic hepatitis C patients treated with direct-acting antivirals between April 2017 and December 2019 from 37 Turkish referral centers were divided into 2 age groups: elderly (>= 65 years) and younger adults (<65 years) and their safety was compared between 2 groups in evaluable population. Then, by matching the 2 age groups for demographics and pretreatment risk factors for a non-sustained virological response, a total of 1516 patients (758 in each group) and 1244 patients (622 in each group) from the modified evaluable population and per-protocol population were included in the efficacy analysis and the efficacy was compared between age groups. Results: The sustained virological response in the chronic hepatitis C patients was not affected by the age and the presence of cirrhosis both in the modified evaluable population and per-protocol population (P =.879, P =.508 for modified evaluable population and P =.058, P =.788 for per-protocol population, respectively). The results of the per-protocol analysis revealed that male gender, patients who had a prior history of hepatocellular carcinoma, patients infected with non-genotype 1 hepatitis C virus, and patients treated with sofosbuvir + ribavirin had a significantly lower sustained virological response 12 rates (P <.001, P =.047, P =.013, and P =.025, respectively). Conclusion: Direct-acting antivirals can be safely used to treat Turkish elderly chronic hepatitis C patients with similar favorable efficacy and safety as that in younger adults.en_US
dc.identifier.doi10.5152/tjg.2022.21271
dc.identifier.endpage873en_US
dc.identifier.issn2148-5607
dc.identifier.issue10en_US
dc.identifier.pmid35946896en_US
dc.identifier.scopus2-s2.0-85139571415en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage862en_US
dc.identifier.trdizinid1134402en_US
dc.identifier.urihttps://doi.org/10.5152/tjg.2022.21271
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1134402
dc.identifier.urihttps://hdl.handle.net/20.500.12483/7455
dc.identifier.volume33en_US
dc.identifier.wosWOS:000955590200007en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAgeen_US
dc.subjectchronic hepatitis Cen_US
dc.subjectdirect-acting antiviral agentsen_US
dc.subjectelderlyen_US
dc.subjectTurkeyen_US
dc.titleEfficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
7455.pdf
Boyut:
3.15 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu